Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/09/634   
Active ingredient: S-[2,3-bispalmitoyloxy-(2R)-propyl]-cysteinyl-GNNDESNISFKEK
Indication: Treatment of pancreatic cancer
Sponsor: MBiotec GmbH
Höhenweg 13, D-82229 Seefeld, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/05/2009 Orphan designation EMEA/OD/101/08 (2009)4056 of 15/05/2009